We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Three Dimensional Paper Sensor Could Test for Disease

By LabMedica International staff writers
Posted on 15 Mar 2012
Image: Origami-inspired paper sensor can be easily assembled by hand. It may soon be able to inexpensively test for diseases like malaria and HIV (Photo courtesy of Alex Wang).
Image: Origami-inspired paper sensor can be easily assembled by hand. It may soon be able to inexpensively test for diseases like malaria and HIV (Photo courtesy of Alex Wang).
Origami-inspired paper sensor could test for malaria and Human Immunodeficiency Virus (HIV) for less than USD 0.10. Sensors can be printed out on an office printer, and take less than a minute to assemble.

These low-cost, "point-of-care" sensors could be useful in the developing world, where resources are often lacking to pay for lab-based tests, and where, even if the money is available, there infrastructure does not exist to transport biological samples to the lab.

Inspired by the paper-folding art of origami, chemists at The University of Texas at Austin (Texas; USA) have developed a 3-D paper sensor that may be able to test for diseases such as malaria and HIV.

One-dimensional paper sensors, such as those used in pregnancy tests, are already common but have limitations. The folded, 3-D sensors, developed by Richard Crooks, the Robert A. Welch professor of chemistry and doctoral student Hong Liu, can test for more substances in a smaller surface area and provide results for more complex tests.

"Anybody can fold them up," said Prof. Crooks. "You don't need a specialist, so you could easily imagine an [non-governmental organization] NGO with some volunteers folding these things up and passing them out. They're easy to produce as well, so the production could be shifted to the clientele as well. They don't need to be made in the developed world."

Prof. Crooks said that the principles underlying the sensor, which have been successfully tested on glucose and a common protein, are related to the home pregnancy test. A hydrophobic material, such as wax or photo resist, is laid down into tiny canyons on chromatography paper. It channels the sample to be tested—urine, blood, or saliva, for instance—to spots on the paper where test reagents have been embedded.

If the sample has whatever targets the sensor is designed to detect, it will react in an easily detectable manner. It might turn a specific color for example or fluoresce under a UV light. Then it can be read by eye.

Related Links:

The University of Texas at Austin


Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Automated Clinical Chemistry Analyzer
Envoy 500+
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA

Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
ADLM